Get started
Author

Hisato Nakai

Observed name: Nakai, Hisato
ORCID: 0000-0002-8961-007X
Observed ORCID: 0000-0002-8961-007X
OpenAlex ID: A5050582075
Cancer-associated venous thromboembolism in the direct oral anticoagulants era: Insight from the COMMAND VTE Registry-2
2024 · Ryuki Chatani, Yugo Yamashita, et al. · Thrombosis Research · 26
Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry‐2
2024 · Nobutaka Ikeda, Yugo Yamashita, et al. · Journal of the American Heart Association · 15
Temporal Changes in Long‐Term Outcomes of Venous Thromboembolism From the Warfarin Era to the Direct Oral Anticoagulant Era
2024 · Kazuhisa Kaneda, Yugo Yamashita, et al. · Journal of the American Heart Association · 11
Prediction Score for Major Bleeding in Patients With Venous Thromboembolism Receiving Direct Oral Anticoagulants ― Insights From the COMMAND VTE Registry-2 ―
2025 · Satoshi Ikeda, Yugo Yamashita, et al. · Circulation Journal · 9
PDF
Newly Diagnosed Cancer After Diagnosis of Venous Thromboembolism ― Insights From the COMMAND VTE Registry-2 ―
2024 · Yugo Yamashita, Takeshi Morimoto, et al. · Circulation Journal · 9
PDF
Clinical characteristics and short-term outcomes of patients with critical acute pulmonary embolism requiring extracorporeal membrane oxygenation: from the COMMAND VTE Registry-2
2024 · Kensuke Takabayashi, Yugo Yamashita, et al. · Journal of Intensive Care · 9
Edoxaban, Rivaroxaban, or Apixaban for Cancer-Associated Venous Thromboembolism in the Real World: Insights from the COMMAND VTE Registry-2
2024 · Daisuke Sueta, Yugo Yamashita, et al. · Thrombosis and Haemostasis · 9
Selection of Home Treatment and Identification of Low‐Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral Anticoagulants
2024 · Ryusuke Nishikawa, Yugo Yamashita, et al. · Journal of the American Heart Association · 5
A Bleeding Risk Score for Cancer-Associated Venous Thromboembolism in Patients Receiving Direct Oral Anticoagulants
2026 · Tomoyuki Nagai, Naohiko Nakanishi, et al. · JACC CardioOncology · 4
PDF
Association Between White Blood Cell Counts at Diagnosis and Clinical Outcomes in Venous Thromboembolism ― From the COMMAND VTE Registry-2 ―
2024 · Shinya Ikeda, Yugo Yamashita, et al. · Circulation Journal · 4
PDF
External validation of the Pulmonary Embolism-Syncope, Anemia, and Renal Dysfunction bleeding score for early major bleeding in patients with acute pulmonary embolism: from the COMMAND VTE Registry-2
2024 · Yuji Nishimoto, Yugo Yamashita, et al. · Journal of Thrombosis and Haemostasis · 4
PDF
Statins use and recurrent venous thromboembolism in the direct oral anticoagulant era: insight from the COMMAND VTE Registry-2
2024 · Hiroshi Mabuchi, Ryusuke Nishikawa, et al. · Journal of Thrombosis and Thrombolysis · 4
Fragility and long-term clinical outcomes in patients with venous thromboembolism receiving direct oral anticoagulants: From the COMMAND VTE REGISTRY-2
2024 · Yoshito Ogihara, Yugo Yamashita, et al. · Thrombosis Research · 4
PDF
Low Body Weight and Long-term Outcomes in Patients with Venous Thromboembolism: Insights from the COMMAND VTE Registry-2
2025 · Soichiro Kobayashi, Yoshito Ogihara, et al. · Thrombosis and Haemostasis · 3
Concomitant Antiplatelet Therapy in Patients With Venous Thromboembolism Treated With Anticoagulants ― Insights From the COMMAND VTE Registry-2 ―
2025 · Kazuhisa Kaneda, Yugo Yamashita, et al. · Circulation Journal · 2
PDF
Management strategies and clinical outcomes of venous thromboembolism in patients with antiphospholipid syndrome in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2
2025 · Takahiro Kuno, Norimichi Koitabashi, et al. · Thrombosis Research · 2
PDF
Subclass phenotypes in patients with unprovoked venous thromboembolisms using a latent class analysis
2024 · Shinya Ikeda, Yugo Yamashita, et al. · Thrombosis Research · 2
PDF
Low Body Weight and Long-Term Outcomes in Cancer-Associated Venous Thromboembolism ― From the COMMAND VTE Registry-2 ―
2026 · Soichiro Kobayashi, Yoshito Ogihara, et al. · Circulation Journal · 1
PDF
Real-world management and outcomes of venous thromboembolism in patients with cancer and limited life expectancy in the direct oral anticoagulant era: insights from the COMMAND VTE Registry-2
2025 · Takahiro Kuno, Norimichi Koitabashi, et al. · Cardio-Oncology · 1
PDF
Sex differences in clinical characteristics, management, and outcomes in patients with venous thromboembolism in the direct oral anticoagulant era: Insight from the COMMAND VTE Registry-2
2025 · Takahiro Kuno, Norimichi Koitabashi, et al. · Thrombosis Update · 1
Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry‐2
2025 · Tatsunori Noto, Nobutaka Ikeda, et al. · Catheterization and Cardiovascular Interventions · 1
Differences in risk factors between all-cause and pulmonary embolism-related death in acute pulmonary embolism: insights from the COMMAND VTE registry-2
2025 · Soichiro Kobayashi, Yoshito Ogihara, et al. · Research and Practice in Thrombosis and Haemostasis · 1
PDF
Edoxaban treatment without initial heparin lead-in for acute venous thromboembolism: insight from the COMMAND VTE registry-2
2025 · Yuta Tsujisaka, Yugo Yamashita, et al. · Journal of Thrombosis and Thrombolysis · 1
Initial anticoagulation therapy with single direct oral anticoagulant in patients with intermediate-high risk acute pulmonary embolism: From the COMMAND VTE Registry-2
2024 · Ryo Shigeno, Kitae Kim, et al. · International Journal of Cardiology · 1
Association of autoimmune diseases and transient risk factors with clinical outcomes in patients with venous thromboembolism: COMMAND VTE registry insights
2026 · Keisuke Okuda, Shinya Ikeda, et al. · Thrombosis Research
Works count: 31
Citation count: 133
H-index: 7
I10-index: 3
Year
Topic
Type